| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.5M | -17.6% | -50.5% |
| SG&A Expense | $5.5M | +77.9% | +102.4% |
| Operating Income | -$7.0M | -42.0% | -21.0% |
| Interest Expense | $100K | +0.0% | +104.1% |
| Net Income | -$7.1M | -18.1% | -10.2% |
| EPS (Basic) | -$13.16 | -141.0% | — |
| EPS (Diluted) | -$13.16 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.8M | +15.2% | +5305.6% |
| Current Assets | $7.1M | +11.1% | +407.8% |
| Total Assets | $8.6M | +7.0% | +185.7% |
| Current Liabilities | $4.3M | -3.4% | -64.4% |
| Total Liabilities | $4.3M | -4.2% | -64.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.9M | — | — |
| Investing Cash Flow | -$1.4M | — | — |
| Financing Cash Flow | $15.7M | — | — |
| -141.0% |
| — |
| $4.3M |
| +21.2% |
| +146.9% |